Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Net Income (2020 - 2025)

iSpecimen has reported Net Income over the past 6 years, most recently at -$2.7 million for Q4 2025.

  • Quarterly results put Net Income at -$2.7 million for Q4 2025, up 55.17% from a year ago — trailing twelve months through Dec 2025 was -$9.0 million (up 30.19% YoY), and the annual figure for FY2025 was -$9.0 million, up 30.19%.
  • Net Income for Q4 2025 was -$2.7 million at iSpecimen, up from -$2.8 million in the prior quarter.
  • Over the last five years, Net Income for ISPC hit a ceiling of $30538.0 in Q4 2021 and a floor of -$6.0 million in Q4 2024.
  • Median Net Income over the past 5 years was -$2.3 million (2022), compared with a mean of -$2.4 million.
  • Biggest five-year swings in Net Income: surged 102.02% in 2021 and later tumbled 7172.11% in 2022.
  • iSpecimen's Net Income stood at $30538.0 in 2021, then tumbled by 7172.11% to -$2.2 million in 2022, then tumbled by 30.96% to -$2.8 million in 2023, then tumbled by 111.96% to -$6.0 million in 2024, then surged by 55.17% to -$2.7 million in 2025.
  • The last three reported values for Net Income were -$2.7 million (Q4 2025), -$2.8 million (Q3 2025), and -$1.8 million (Q2 2025) per Business Quant data.